Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells

被引：20
|
作者：
Lu, L. [1 ,2 ]
Saunders, V. A. [1 ]
Leclercq, T. M. [1 ,2 ]
Hughes, T. P. [1 ,2 ,3 ]
White, D. L. [1 ,2 ,4 ]
机构：
[1] South Australian Hlth & Med Res Inst SAHMRI, Canc Theme, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Med, Discipline Med, Adelaide, SA, Australia
[3] SA Pathol, Dept Haematol, Adelaide, SA, Australia
[4] Univ Adelaide, Sch Med, Discipline Paediat, Adelaide, SA, Australia
来源：
LEUKEMIA | 2015年 / 29卷 / 08期
关键词：
IN-VITRO SENSITIVITY; IMATINIB MESYLATE; LEUKEMIA-CELLS; P-GLYCOPROTEIN; RESISTANCE; INHIBITOR; EFFLUX; ABL;
D O I：
10.1038/leu.2015.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1792 / 1794
页数：3
相关论文
共 50 条
  • [41] Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells
    Kosztyu, Petr
    Bukvova, Romana
    Dolezel, Petr
    Mlejnek, Petr
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 219 : 203 - 210
  • [42] The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
    Wang Yin
    Dongxi Xiang
    Tao Wang
    Yumei Zhang
    Cuong V. Pham
    Shufeng Zhou
    Guoqin Jiang
    Yingchun Hou
    Yimin Zhu
    Yinglu Han
    Liang Qiao
    Phuong H.-L. Tran
    Wei Duan
    Scientific Reports, 11
  • [43] Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
    Moritz C Oberstadt
    Sandra Bien-Möller
    Kerstin Weitmann
    Susann Herzog
    Katharina Hentschel
    Christian Rimmbach
    Silke Vogelgesang
    Ellen Balz
    Matthias Fink
    Heike Michael
    Jan-Philip Zeden
    Henrike Bruckmüller
    Anneke N Werk
    Ingolf Cascorbi
    Wolfgang Hoffmann
    Dieter Rosskopf
    Henry WS Schroeder
    Heyo K Kroemer
    BMC Cancer, 13
  • [44] Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
    Wu, Chung-Pu
    Hsiao, Sung-Han
    Wu, Yu-Shan
    DRUG RESISTANCE UPDATES, 2023, 71
  • [45] Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
    Gardner, Erin R.
    Smith, Nicola F.
    Figg, William D.
    Sparreboom, Alex
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [46] Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
    Lal, Suman
    Wong, Zee Wan
    Sandanaraj, Edwin
    Xiang, Xiaoqiang
    Ang, Peter Cher Siang
    Lee, Edmund J. D.
    Chowbay, Balram
    CANCER SCIENCE, 2008, 99 (04) : 816 - 823
  • [47] Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
    Oberstadt, Moritz C.
    Bien-Moeller, Sandra
    Weitmann, Kerstin
    Herzog, Susann
    Hentschel, Katharina
    Rimmbach, Christian
    Vogelgesang, Silke
    Balz, Ellen
    Fink, Matthias
    Michael, Heike
    Zeden, Jan-Philip
    Bruckmueller, Henrike
    Werk, Anneke N.
    Cascorbi, Ingolf
    Hoffmann, Wolfgang
    Rosskopf, Dieter
    Schroeder, Henry W. S.
    Kroemer, Heyo K.
    BMC CANCER, 2013, 13
  • [48] Clinical significance of the ABCB1 and ABCG2 gene expression levels in acute lymphoblastic leukemia
    Olarte Carrillo, I.
    Ramos Penafiel, C.
    Miranda Peralta, E.
    Rozen Fuller, E.
    Kassack Ipina, J. J.
    Centeno Cruz, F.
    Garrido Guerrero, E.
    Collazo Jaloma, J.
    Nacho Vargas, K.
    Martinez Tovar, A.
    HEMATOLOGY, 2017, 22 (05) : 286 - 291
  • [49] Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
    Lepper, ER
    Nooter, K
    Verweij, J
    Acharya, M
    Figg, WD
    Sparreboom, A
    PHARMACOGENOMICS, 2005, 6 (02) : 115 - 138
  • [50] Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
    Erin R Gardner
    Nicola F Smith
    William D Figg
    Alex Sparreboom
    Journal of Experimental & Clinical Cancer Research, 28
12345